492029 Sigma-AldrichNRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant
Recommended Products
Přehled
Replacement Information |
---|
Tabulka spec. kláve
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from 0.2 µm filtered acetonitrile, TFA, BSA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 0.06-0.3 ng/ml as measured in a serum-free proliferation assay using MCF-7 human breast adenocarcinoma cells. |
Purity | ≥97% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1.0 EU/µg protein |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Katalogové číslo | GTIN |
492029 | 0 |
Documentation
NRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant MSDS
Title |
---|
NRG1-β1/HRG1-β1 EGF Domain, Human, Recombinant Certificates of Analysis
Title | Lot Number |
---|---|
492029 |
References
Přehled odkazů |
---|
Buonanno, A., and Fischbach, G.D. 2001. Curr. Opin. Neurobiol. 11, 287. Adlkofer, K. and Lai, C. 2000. Glia 29, 104. Garratt, A.N. et al. 2000. BioEssays 22, 987. Karey, K.P., et al. 1988. Cancer Res. 48, 4083. |